Strides Pharma Science has reported results for first quarter ended June 30, 2021.
The company has reported in its net loss of Rs 21.23 crore for the quarter under review as compared to net profit of Rs 0.89 crore for the same quarter in the previous year. However, total income of the company increased by 21.97% at Rs 517.54 crore for Q1FY22 as compared Rs 424.32 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a net loss attributed to the owners of Rs 205.20 crore for the quarter under review as compared to net profit of Rs 103.56 crore for the same quarter in the previous year. Total income of the company decreased by 11.61% at Rs 701.90 crore for Q1FY22 as compared Rs 794.10 crore for the corresponding quarter previous year.
